JOANNIE POMPEE: Open Payments
NPI 1982388047 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,306 in 136 payments from 19 companies in 2025. Trend: 2023 $697 · 2024 $2,241 · 2025 $3,306
Food & beverage: $3,220Education: $86
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 20 | $742 |
| Janssen Biotech, Inc. | 24 | $561 |
| GENZYME CORPORATION | 13 | $447 |
| Regeneron Healthcare Solutions, Inc. | 18 | $305 |
| ABBVIE INC. | 19 | $265 |
| LEO Pharma Inc. | 12 | $262 |
| Galderma Laboratories, L.P. | 8 | $221 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $75 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
Products named: DUPIXENT, OPZELURA, TREMFYA, NEMLUVIO, ADBRY, SKYRIZI, RINVOQ, COSENTYX.
Industry payments across CT — which companies pay providers there.
